Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Tester

Showing results (81-90 of 212) with videos related to

Pageof 22
Sort By:
Human Mutation|March 30, 2012
Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained deathJohn R Giudicessi, Dan Ye, Chad J Kritzberger, et al.
Heart Rhythm|September 8, 2019
Utilization of the genome aggregation database, in silico tools, and heterologous expression patch-clamp studies to identify and demote previously published type 2 long QT syndrome: Causative variants from pathogenic to likely benignConnor L Mattivi, Dan Ye, David J Tester, et al.
Circulation|April 30, 2015
Homozygous/Compound Heterozygous Triadin Mutations Associated With Autosomal-Recessive Long-QT Syndrome and Pediatric Sudden Cardiac Arrest: Elucidation of the Triadin Knockout SyndromeHelene M Altmann, David J Tester, Melissa L Will, et al.
Circulation. Arrhythmia and Electrophysiology|July 29, 2024
Single Construct Suppression and Replacement Gene Therapy for the Treatment of All <i>CALM1</i>-, <i>CALM2</i>-, and <i>CALM3</i>-Mediated Arrhythmia DisordersSamantha K Hamrick, C S John Kim, David J Tester, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2008
Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complexKazuo Ueda, Carmen Valdivia, Argelia Medeiros-Domingo, et al.
Heart Rhythm|July 5, 2006
Allelic dropout in long QT syndrome genetic testing: a possible mechanism underlying false-negative resultsDavid J Tester, Lisa B Cronk, Janet L Carr, et al.
Circulation|October 31, 2007
Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndromeDavid W Van Norstrand, Carmen R Valdivia, David J Tester, et al.
Mayo Clinic Proceedings|February 3, 2024
Temporal Association Between Vaping and Risk of Cardiac EventsSahej Bains, Ramin Garmany, Raquel Neves, et al.
Circulation. Genomic and Precision Medicine|October 17, 2022
Suppression and Replacement Gene Therapy for <i>KCNH2</i>-Mediated ArrhythmiasSahej Bains, Wei Zhou, Steven M Dotzler, et al.
Heart Rhythm|January 7, 2023
SGK1 inhibition attenuates the action potential duration in reengineered heart cell models of drug-induced QT prolongationMaengjo Kim, Philip T Sager, David J Tester, et al.
Pageof 22

Showing results (81-90 of 212) with videos related to

Sort By:
Pageof 22
Human Mutation|March 30, 2012
Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained deathJohn R Giudicessi, Dan Ye, Chad J Kritzberger, et al.
Heart Rhythm|September 8, 2019
Utilization of the genome aggregation database, in silico tools, and heterologous expression patch-clamp studies to identify and demote previously published type 2 long QT syndrome: Causative variants from pathogenic to likely benignConnor L Mattivi, Dan Ye, David J Tester, et al.
Circulation|April 30, 2015
Homozygous/Compound Heterozygous Triadin Mutations Associated With Autosomal-Recessive Long-QT Syndrome and Pediatric Sudden Cardiac Arrest: Elucidation of the Triadin Knockout SyndromeHelene M Altmann, David J Tester, Melissa L Will, et al.
Circulation. Arrhythmia and Electrophysiology|July 29, 2024
Single Construct Suppression and Replacement Gene Therapy for the Treatment of All <i>CALM1</i>-, <i>CALM2</i>-, and <i>CALM3</i>-Mediated Arrhythmia DisordersSamantha K Hamrick, C S John Kim, David J Tester, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2008
Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complexKazuo Ueda, Carmen Valdivia, Argelia Medeiros-Domingo, et al.
Heart Rhythm|July 5, 2006
Allelic dropout in long QT syndrome genetic testing: a possible mechanism underlying false-negative resultsDavid J Tester, Lisa B Cronk, Janet L Carr, et al.
Circulation|October 31, 2007
Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndromeDavid W Van Norstrand, Carmen R Valdivia, David J Tester, et al.
Mayo Clinic Proceedings|February 3, 2024
Temporal Association Between Vaping and Risk of Cardiac EventsSahej Bains, Ramin Garmany, Raquel Neves, et al.
Circulation. Genomic and Precision Medicine|October 17, 2022
Suppression and Replacement Gene Therapy for <i>KCNH2</i>-Mediated ArrhythmiasSahej Bains, Wei Zhou, Steven M Dotzler, et al.
Heart Rhythm|January 7, 2023
SGK1 inhibition attenuates the action potential duration in reengineered heart cell models of drug-induced QT prolongationMaengjo Kim, Philip T Sager, David J Tester, et al.
Pageof 22